Stephen Konieczny

Stephen Konieczny

Purdue University

H-index: 60

North America-United States

About Stephen Konieczny

Stephen Konieczny, With an exceptional h-index of 60 and a recent h-index of 30 (since 2020), a distinguished researcher at Purdue University, specializes in the field of Cancer and Development.

His recent articles reflect a diverse array of research interests and contributions to the field:

The Xbp1-regulated transcription factor Mist1 restricts antibody secretion by restraining Blimp1 expression in plasma cells

Targeting Plk1 sensitizes pancreatic cancer to immune checkpoint therapy

CRISPR/Cas12a‐mediated CHO genome engineering can be effectively integrated at multiple stages of the cell line generation process for bioproduction

EVALUATION OF THERAPEUTIC POTENTIAL OF PTF1A ACTIVATION TO TREAT PANCREATIC CANCER USING A MICROFLUIDIC PANCREATIC ACINAR MODEL

Engineering of a functional pancreatic acinus with reprogrammed cancer cells by induced PTF1a expression

Thrombin‐PAR1 signaling in pancreatic cancer promotes an immunosuppressive microenvironment

Subtype-specific characterization of breast cancer invasion using a microfluidic tumor platform

A biomimetic tumor model of heterogeneous invasion in pancreatic ductal adenocarcinoma

Stephen Konieczny Information

University

Position

Professor Emeritus

Citations(all)

12368

Citations(since 2020)

2898

Cited By

10409

hIndex(all)

60

hIndex(since 2020)

30

i10Index(all)

103

i10Index(since 2020)

64

Email

University Profile Page

Purdue University

Google Scholar

View Google Scholar Profile

Stephen Konieczny Skills & Research Interests

Cancer and Development

Top articles of Stephen Konieczny

Title

Journal

Author(s)

Publication Date

The Xbp1-regulated transcription factor Mist1 restricts antibody secretion by restraining Blimp1 expression in plasma cells

Frontiers in Immunology

Miriam Wöhner

Theresa Pinter

Peter Bönelt

Astrid Hagelkruys

Daniela Kostanova-Poliakova

...

2022/12/21

Targeting Plk1 sensitizes pancreatic cancer to immune checkpoint therapy

Cancer research

Zhuangzhuang Zhang

Lijun Cheng

Jie Li

Qi Qiao

Anju Karki

...

2022/10/4

CRISPR/Cas12a‐mediated CHO genome engineering can be effectively integrated at multiple stages of the cell line generation process for bioproduction

Biotechnology Journal

Patrick G Schweickert

Ning Wang

Stephanie L Sandefur

Michael E Lloyd

Stephen F Konieczny

...

2021/4

EVALUATION OF THERAPEUTIC POTENTIAL OF PTF1A ACTIVATION TO TREAT PANCREATIC CANCER USING A MICROFLUIDIC PANCREATIC ACINAR MODEL

Hye Ran Moon

Stephanie M Venis

Yi Yang

Sagar M Utturkar

Stephen F Konieczny

...

2021

Engineering of a functional pancreatic acinus with reprogrammed cancer cells by induced PTF1a expression

Lab on a Chip

Stephanie M Venis

Hye-ran Moon

Yi Yang

Sagar M Utturkar

Stephen F Konieczny

...

2021

Thrombin‐PAR1 signaling in pancreatic cancer promotes an immunosuppressive microenvironment

Journal of Thrombosis and Haemostasis

Patrick G Schweickert

Yi Yang

Emily E White

Gregory M Cresswell

Bennett D Elzey

...

2021/1/1

Subtype-specific characterization of breast cancer invasion using a microfluidic tumor platform

PLoS One

Hye-ran Moon

Natalia Ospina-Muñoz

Victoria Noe-Kim

Yi Yang

Bennett D Elzey

...

2020/6/16

A biomimetic tumor model of heterogeneous invasion in pancreatic ductal adenocarcinoma

Small

Michael J Bradney

Stephanie M Venis

Yi Yang

Stephen F Konieczny

Bumsoo Han

2020/3

An engineered pancreatic cancer model with intra-tumoral heterogeneity of driver mutations

Lab on a Chip

Hye-ran Moon

Altug Ozcelikkale

Yi Yang

Bennett D Elzey

Stephen F Konieczny

...

2020

Thrombin Signaling Promotes Pancreatic Adenocarcinoma Through PAR-1-Dependent Immune Evasion

Cancer research

Yi Yang

Amanda Stang

Patrick G Schweickert

Nadia A Lanman

Erin N Paul

...

2019/7/1

See List of Professors in Stephen Konieczny University(Purdue University)